624
Participants
Start Date
November 30, 2000
Ritonavir
Abacavir sulfate
Nelfinavir mesylate
Lamivudine
GW433908
St Lukes - Roosevelt Hosp Ctr, New York
Bronx Veterans Affairs Med Ctr, The Bronx
North Shore Univ Hosp, Manhasset
SUNY / Erie County Med Ctr at Buffalo, Buffalo
Hahnemann Univ Hosp, Philadelphia
Burnside Clinic, Columbia
SMO USA, Conyers
AIDS Research Consortium of Atlanta, Atlanta
Med College of Georgia, Augusta
Infectious Disease Consultants, Altamonte Springs
Univ of Miami Dept of Medicine, Miami
Specialty Med Care Ctrs of South Florida Inc, Miami
CRI of South Florida, Coral Gables
Therafirst Med Ctr, Fort Lauderdale
Gary Richmond MD, Fort Lauderdale
Infectious Disease Research Inst, Tampa
Jeffrey Levenson, St. Petersburg
Infectious Diseases Associates, Sarasota
Methodist Healthcare, Memphis
Indiana Univ Med School, Indianapolis
Abbott-Northwestern Hosp / Clinic 42, Minneapolis
Southampton Healthcare Inc, St Louis
Nicholas Bellos, Dallas
Joseph C Gathe, Houston
AIDS Healthcare Foundation, Los Angeles
LAGLC, Los Angeles
AIDS Research Alliance, West Hollywood
Park Ctr for Health / Keith Vrhel, San Diego
Orange County Ctr for Special Immunology, Fountain Valley
Kaiser Hospital, Sacramento
Milton S Hershey Med Ctr, Hershey
Dupont Circle Physicians Group, Washington D.C.
Univ of Cincinnati / Holmes Hosp, Cincinnati
Brigham and Women's Hosp, Boston
Hawthorne Med Associates / PAACA, New Bedford
VAMC New Jersey Healthcare System, East Orange
North Jersey Community Research Initiative, Newark
Lead Sponsor
Glaxo Wellcome
INDUSTRY